AimingMed
PrivateLast Round
Strategic
Jan 3, 2024
Total Funding Raised
$3.13M
Company Overview
AimingMed operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Strategic round in January 2024.
AimingMed is a biotechnology company that specializes in organoid technology, providing precision treatment solutions, drug screening, and research services for oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AimingMed Comparables
Compare AimingMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Accurate International Biotechnology | 93% | |
| bioGenous Biotechnology | 90% | |
| K2 Oncology | 88% |
For institutional investors. Book with your work email.
AimingMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 3, 2024 | ||||
| Early Funding | Nov 7, 2022 | ||||
| Angel | Oct 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AimingMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yuanjing Capital | Early Funding, Angel |
| Yantai Guofeng Investment Holding Group Co., Ltd. | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 3, 2024
Led by Yantai Guofeng Investment Holding Group Co., Ltd.
- Nov 7, 2022
Raised capital from Yuanjing Capital.
For institutional investors. Book with your work email.
AimingMed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AimingMed's valuation, stock price, and market status.
Is AimingMed a public or private company?
AimingMed is a private company.
What is the current stock price of AimingMed?
AimingMed is a private company, so its shares have no public market price. Caplight tracks AimingMed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AimingMed worth (valuation)?
Valuation information for AimingMed is not publicly available.
Can I buy AimingMed stock?
AimingMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AimingMed's last funding round?
AimingMed's most recent funding round was Strategic on January 3, 2024.
Who are the main investors in AimingMed?
Key investors in AimingMed include Yuanjing Capital, Yantai Guofeng Investment Holding Group Co., Ltd..
Will AimingMed IPO soon?
No public IPO plans have been announced for AimingMed.
How can I track AimingMed secondary market activity?
Caplight tracks bids, offers, and trades in AimingMed's shares on secondary markets.